{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:24:04Z","timestamp":1793733844665,"version":"4.6.1"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970557"],"award-info":[{"award-number":["31970557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2700900"],"award-info":[{"award-number":["2021YFC2700900"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mitochondria are essential organelles for cellular metabolism and physiology in eukaryotic cells. Human mitochondria have their own genome (mtDNA), which is maternally inherited with 37 genes, encoding 13 polypeptides for oxidative phosphorylation, and 22 tRNAs and 2 rRNAs for translation. mtDNA mutations are associated with a wide spectrum of degenerative and neuromuscular diseases. However, the pathophysiology of mitochondrial diseases, especially for threshold effect and tissue specificity, is not well understood and there is no effective treatment for these disorders. Especially, the lack of appropriate cell and animal disease models has been significant obstacles for deep elucidating the pathophysiology of maternally transmitted diseases and developing the effective therapy approach. The use of human induced pluripotent stem cells (iPSCs) derived from patients to obtain terminally differentiated specific lineages such as inner ear hair cells is a revolutionary approach to deeply understand pathogenic mechanisms and develop the therapeutic interventions of mitochondrial disorders. Here, we review the recent advances in patients-derived iPSCs as ex vivo models for mitochondrial diseases. Those patients-derived iPSCs have been differentiated into specific targeting cells such as retinal ganglion cells and eventually organoid for the disease modeling. These disease models have advanced our understanding of the pathophysiology of maternally inherited diseases and stepped toward therapeutic interventions for these diseases.<\/jats:p>","DOI":"10.1186\/s12929-023-00967-7","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T06:02:30Z","timestamp":1695362550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations"],"prefix":"10.1186","volume":"30","author":[{"given":"Chao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5067-6736","authenticated-orcid":false,"given":"Min-Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"967_CR1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41588-018-0264-z","volume":"50","author":"DC Wallace","year":"2018","unstructured":"Wallace DC. Mitochondrial genetic medicine. Nat Genet. 2018;50:1642\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"967_CR2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145\u201359.","journal-title":"Cell"},{"issue":"7","key":"967_CR3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","volume":"125","author":"DC Chan","year":"2006","unstructured":"Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125(7):1241\u201352.","journal-title":"Cell"},{"issue":"11","key":"967_CR4","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","volume":"34","author":"M Picard","year":"2022","unstructured":"Picard M, Shirihai OS. Mitochondrial signal transduction. Cell Metab. 2022;34(11):1620\u201353.","journal-title":"Cell Metab"},{"issue":"5","key":"967_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41580-018-0092-0","volume":"20","author":"N Pfanner","year":"2019","unstructured":"Pfanner N, Warscheid B, Wiedemann N. Mitochondrial proteins: from biogenesis to functional networks. Nat Rev Mol Cell Biol. 2019;20(5):267\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"967_CR6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cmet.2014.07.001","volume":"20","author":"BM Hallberg","year":"2014","unstructured":"Hallberg BM, Larsson NG. Making proteins in the powerhouse. Cell Metab. 2014;20(2):226\u201340.","journal-title":"Cell Metab"},{"issue":"5806","key":"967_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","volume":"290","author":"S Anderson","year":"1981","unstructured":"Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457\u201365.","journal-title":"Nature"},{"issue":"3","key":"967_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/EBC20170100","volume":"62","author":"M Falkenberg","year":"2018","unstructured":"Falkenberg M. Mitochondrial DNA replication in mammalian cells: overview of the pathway. Essays Biochem. 2018;62(3):287\u201396.","journal-title":"Essays Biochem"},{"issue":"2","key":"967_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ajmg.1320570226","volume":"57","author":"X Chen","year":"1995","unstructured":"Chen X, Prosser R, Simonetti S, Sadlock J, Jagiello G, Schon EA. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet. 1995;57(2):239\u201347.","journal-title":"Am J Hum Genet"},{"key":"967_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mito.2014.10.005","volume":"20","author":"AM D'Erchia","year":"2015","unstructured":"D\u2019Erchia AM, Atlante A, Gadaleta G, Pavesi G, Chiara M, De Virgilio C, et al. Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity. Mitochondrion. 2015;20:13\u201321.","journal-title":"Mitochondrion"},{"issue":"9","key":"967_CR11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/1471-0528.17078","volume":"129","author":"D Popova","year":"2022","unstructured":"Popova D, Bhide P, D\u2019Antonio F, Basnet P, Acharya G. Sperm mitochondrial DNA copy numbers in normal and abnormal semen analysis: a systematic review and meta-analysis. BJOG. 2022;129(9):1434\u201346.","journal-title":"BJOG"},{"issue":"2","key":"967_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/antiox10020139","volume":"10","author":"P May-Panloup","year":"2021","unstructured":"May-Panloup P, Boguenet M, Hachem HE, Bouet PE, Reynier P. Embryo and its mitochondria. Antioxidants (Basel). 2021;10(2):139.","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"967_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbabio.2009.09.005","volume":"1797","author":"HA Tuppen","year":"2010","unstructured":"Tuppen HA, Blakely EL, Turnbull DM, Taylor RW. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 2010;1797(2):113\u201328.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"967_CR14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-017-0027-5","volume":"40","author":"C Viscomi","year":"2017","unstructured":"Viscomi C, Zeviani M. MtDNA-maintenance defects: syndromes and genes. J Inherit Metab Dis. 2017;40(4):587\u201399.","journal-title":"J Inherit Metab Dis"},{"issue":"9828","key":"967_CR15","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(11)61305-6","volume":"379","author":"AH Schapira","year":"2012","unstructured":"Schapira AH. Mitochondrial diseases. Lancet. 2012;379(9828):1825\u201334.","journal-title":"Lancet"},{"issue":"7288","key":"967_CR16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nature08802","volume":"464","author":"Y He","year":"2010","unstructured":"He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. 2010;464(7288):610\u20134.","journal-title":"Nature"},{"issue":"5","key":"967_CR17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77(5):753\u20139.","journal-title":"Ann Neurol"},{"key":"967_CR18","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2:16080.","journal-title":"Nat Rev Dis Primers"},{"issue":"6302","key":"967_CR19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","volume":"348","author":"Y Goto","year":"1990","unstructured":"Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348(6302):651\u20133.","journal-title":"Nature"},{"issue":"6","key":"967_CR20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","volume":"61","author":"JM Shoffner","year":"1990","unstructured":"Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell. 1990;61(6):931\u20137.","journal-title":"Cell"},{"issue":"6","key":"967_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ana.410340612","volume":"34","author":"FM Santorelli","year":"1993","unstructured":"Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh\u2019s syndrome. Ann Neurol. 1993;34(6):827\u201334.","journal-title":"Ann Neurol"},{"issue":"1","key":"967_CR22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/ijms23010210","volume":"23","author":"M Zeviani","year":"2021","unstructured":"Zeviani M, Carelli V. Mitochondrial retinopathies. Int J Mol Sci. 2021;23(1):210.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"967_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0793-289","volume":"4","author":"TR Prezant","year":"1993","unstructured":"Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993;4(3):289\u201394.","journal-title":"Nat Genet"},{"issue":"1","key":"967_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/381133","volume":"74","author":"H Zhao","year":"2004","unstructured":"Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, et al. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet. 2004;74(1):139\u201352.","journal-title":"Am J Hum Genet"},{"key":"967_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","volume":"1142","author":"DM Sproule","year":"2008","unstructured":"Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann Ny Acad Sci. 2008;1142:133\u201358.","journal-title":"Ann Ny Acad Sci"},{"key":"967_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106466","volume":"185","author":"MR Chiaratti","year":"2022","unstructured":"Chiaratti MR, Chinnery PF. Modulating mitochondrial DNA mutations: factors shaping heteroplasmy in the germ line and somatic cells. Pharmacol Res. 2022;185: 106466.","journal-title":"Pharmacol Res"},{"issue":"3","key":"967_CR27","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949612","volume":"21","author":"N Nissanka","year":"2020","unstructured":"Nissanka N, Moraes CT. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches. EMBO Rep. 2020;21(3): e49612.","journal-title":"EMBO Rep"},{"issue":"9","key":"967_CR28","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1172\/JCI134965","volume":"130","author":"J Yu","year":"2020","unstructured":"Yu J, Liang X, Ji Y, Ai C, Liu J, Zhu L, et al. PRICKLE3 linked to ATPase biogenesis manifested Leber\u2019s hereditary optic neuropathy. J Clin Invest. 2020;130(9):4935\u201346.","journal-title":"J Clin Invest"},{"issue":"3","key":"967_CR29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/hmg\/ddv498","volume":"25","author":"P Jiang","year":"2016","unstructured":"Jiang P, Jin X, Peng Y, Wang M, Liu H, Liu X, et al. The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber\u2019s hereditary optic neuropathy-associated mitochondrial DNA mutation. Hum Mol Genet. 2016;25(3):584\u201396.","journal-title":"Hum Mol Genet"},{"key":"967_CR30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mito.2017.07.004","volume":"36","author":"L Caporali","year":"2017","unstructured":"Caporali L, Maresca A, Capristo M, Del Dotto V, Tagliavini F, Valentino ML, et al. Incomplete penetrance in mitochondrial optic neuropathies. Mitochondrion. 2017;36:130\u20137.","journal-title":"Mitochondrion"},{"issue":"2","key":"967_CR31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/506389","volume":"79","author":"MX Guan","year":"2006","unstructured":"Guan MX, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P, et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet. 2006;79(2):291\u2013302.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"967_CR32","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1074\/jbc.M116.749374","volume":"292","author":"F Meng","year":"2017","unstructured":"Meng F, Cang X, Peng Y, Li R, Zhang Z, Li F, et al. Biochemical evidence for a nuclear modifier allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) related to mitochondrial tRNA modification in the phenotypic manifestation of deafness-associated 12S rRNA Mutation. J Biol Chem. 2017;292(7):2881\u201392.","journal-title":"J Biol Chem"},{"issue":"9","key":"967_CR33","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/ddy450","volume":"28","author":"Y Ji","year":"2019","unstructured":"Ji Y, Zhang J, Yu J, Wang Y, Lu Y, Liang M, et al. Contribution of mitochondrial ND1 3394T>C mutation to the phenotypic manifestation of Leber\u2019s hereditary optic neuropathy. Hum Mol Genet. 2019;28(9):1515\u201329.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"967_CR34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1167\/iovs.05-0665","volume":"47","author":"J Qu","year":"2006","unstructured":"Qu J, Li R, Zhou X, Tong Y, Lu F, Qian Y, et al. The novel A4435G mutation in the mitochondrial tRNAMet may modulate the phenotypic expression of the LHON-associated ND4 G11778A mutation. Invest Ophthalmol Vis Sci. 2006;47(2):475\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"38","key":"967_CR35","doi-asserted-by":"crossref","first-page":"13224","DOI":"10.1074\/jbc.RA120.014603","volume":"295","author":"Y Ji","year":"2020","unstructured":"Ji Y, Zhang J, Lu Y, Yi Q, Chen M, Xie S, et al. Complex I mutations synergize to worsen the phenotypic expression of Leber\u2019s hereditary optic neuropathy. J Biol Chem. 2020;295(38):13224\u201338.","journal-title":"J Biol Chem"},{"issue":"2","key":"967_CR36","volume":"297","author":"Q He","year":"2021","unstructured":"He Q, He X, Xiao Y, Zhao Q, Ye Z, Cui L, et al. Tissue-specific expression atlas of murine mitochondrial tRNAs. J Biol Chem. 2021;297(2): 100960.","journal-title":"J Biol Chem"},{"issue":"8","key":"967_CR37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jnnp-2012-303528","volume":"84","author":"V Nesbitt","year":"2013","unstructured":"Nesbitt V, Pitceathly RD, Turnbull DM, Taylor RW, Sweeney MG, Mudanohwo EE, et al. The UK MRC Mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A>G mutation\u2014implications for diagnosis and management. J Neurol Neurosurg Psychiatry. 2013;84(8):936\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"967_CR38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53\u201389.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"967_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mito.2010.10.006","volume":"11","author":"MX Guan","year":"2011","unstructured":"Guan MX. Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion. 2011;11(2):237\u201345.","journal-title":"Mitochondrion"},{"issue":"6255","key":"967_CR40","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.aac7516","volume":"349","author":"RN Lightowlers","year":"2015","unstructured":"Lightowlers RN, Taylor RW, Turnbull DM. Mutations causing mitochondrial disease: what is new and what challenges remain? Science. 2015;349(6255):1494\u20139.","journal-title":"Science"},{"issue":"1","key":"967_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.stem.2019.06.010","volume":"25","author":"A Yilmaz","year":"2019","unstructured":"Yilmaz A, Benvenisty N. Defining human pluripotency. Cell Stem Cell. 2019;25(1):9\u201322.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"967_CR42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27(4):523\u201331.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"967_CR43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"5","key":"967_CR44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"2","key":"967_CR45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/pharmaceutics14020317","volume":"14","author":"A Bailly","year":"2022","unstructured":"Bailly A, Milhavet O, Lemaitre JM. RNA-based strategies for cell reprogramming toward pluripotency. Pharmaceutics. 2022;14(2):317.","journal-title":"Pharmaceutics"},{"issue":"5858","key":"967_CR46","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320.","journal-title":"Science"},{"issue":"11","key":"967_CR47","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/nprot.2012.121","volume":"7","author":"SN Dowey","year":"2012","unstructured":"Dowey SN, Huang X, Chou BK, Ye Z, Cheng L. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc. 2012;7(11):2013\u201321.","journal-title":"Nat Protoc"},{"issue":"12","key":"967_CR48","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/nprot.2012.115","volume":"7","author":"T Zhou","year":"2012","unstructured":"Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc. 2012;7(12):2080\u20139.","journal-title":"Nat Protoc"},{"issue":"27","key":"967_CR49","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2009-04-217406","volume":"114","author":"Z Ye","year":"2009","unstructured":"Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009;114(27):5473\u201380.","journal-title":"Blood"},{"issue":"1","key":"967_CR50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.stem.2010.06.002","volume":"7","author":"J Staerk","year":"2010","unstructured":"Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell. 2010;7(1):20\u20134.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"967_CR51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nprot.2009.241","volume":"5","author":"T Aasen","year":"2010","unstructured":"Aasen T, Izpisua Belmonte JC. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc. 2010;5(2):371\u201382.","journal-title":"Nat Protoc"},{"issue":"1","key":"967_CR52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12015-015-9622-8","volume":"12","author":"M Brouwer","year":"2016","unstructured":"Brouwer M, Zhou H, Nadif KN. Choices for induction of pluripotency: recent developments in human induced pluripotent stem cell reprogramming strategies. Stem Cell Rev Rep. 2016;12(1):54\u201372.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"967_CR53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stem.2009.12.001","volume":"6","author":"MA Esteban","year":"2010","unstructured":"Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell. 2010;6(1):71\u20139.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"967_CR54","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nbt.1502","volume":"26","author":"D Huangfu","year":"2008","unstructured":"Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26(11):1269\u201375.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"967_CR55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/stem.402","volume":"28","author":"P Mali","year":"2010","unstructured":"Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells. 2010;28(4):713\u201320.","journal-title":"Stem Cells"},{"issue":"7200","key":"967_CR56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature07056","volume":"454","author":"TS Mikkelsen","year":"2008","unstructured":"Mikkelsen TS, Hanna J, Zhang XL, Ku MC, Wernig M, Schorderet P, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature. 2008;454(7200):49-U1.","journal-title":"Nature"},{"issue":"7239","key":"967_CR57","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature07864","volume":"458","author":"K Kaji","year":"2009","unstructured":"Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 2009;458(7239):771\u20135.","journal-title":"Nature"},{"issue":"7239","key":"967_CR58","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","volume":"458","author":"K Woltjen","year":"2009","unstructured":"Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009;458(7239):766\u201370.","journal-title":"Nature"},{"issue":"11","key":"967_CR59","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/stem.201","volume":"27","author":"WB Zhou","year":"2009","unstructured":"Zhou WB, Freed CR. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells. 2009;27(11):2667\u201374.","journal-title":"Stem Cells"},{"issue":"8","key":"967_CR60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5966\/sctm.2013-0006","volume":"2","author":"L Ye","year":"2013","unstructured":"Ye L, Muench MO, Fusaki N, Beyer AI, Wang J, Qi Z, et al. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med. 2013;2(8):558\u201366.","journal-title":"Stem Cells Transl Med"},{"issue":"5928","key":"967_CR61","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324(5928):797\u2013801.","journal-title":"Science"},{"issue":"5","key":"967_CR62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","volume":"4","author":"H Zhou","year":"2009","unstructured":"Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4(5):381\u20134.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"967_CR63","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618\u201330.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"967_CR64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.stem.2013.06.001","volume":"13","author":"N Yoshioka","year":"2013","unstructured":"Yoshioka N, Gros E, Li HR, Kumar S, Deacon DC, Maron C, et al. Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell. 2013;13(2):246\u201354.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"967_CR65","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.stem.2011.03.001","volume":"8","author":"F Anokye-Danso","year":"2011","unstructured":"Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell. 2011;8(4):376\u201388.","journal-title":"Cell Stem Cell"},{"issue":"6146","key":"967_CR66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.1239278","volume":"341","author":"P Hou","year":"2013","unstructured":"Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341(6146):651\u20134.","journal-title":"Science"},{"issue":"2","key":"967_CR67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16(2):115\u201330.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"967_CR68","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/s41467-021-25482-x","volume":"12","author":"W Wei","year":"2021","unstructured":"Wei W, Gaffney DJ, Chinnery PF. Cell reprogramming shapes the mitochondrial DNA landscape. Nat Commun. 2021;12(1):5241.","journal-title":"Nat Commun"},{"issue":"2","key":"967_CR69","first-page":"117","volume":"4","author":"JA Maceluch","year":"2006","unstructured":"Maceluch JA, Niedziela M. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy. Pediatr Endocrinol Rev. 2006;4(2):117\u201337.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"9","key":"967_CR70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1212\/WNL.38.9.1339","volume":"38","author":"M Zeviani","year":"1988","unstructured":"Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology. 1988;38(9):1339\u201346.","journal-title":"Neurology"},{"issue":"8643","key":"967_CR71","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(89)92897-3","volume":"1","author":"A Rotig","year":"1989","unstructured":"Rotig A, Colonna M, Bonnefont JP, Blanche S, Fischer A, Saudubray JM, et al. Mitochondrial DNA deletion in Pearson\u2019s marrow\/pancreas syndrome. Lancet. 1989;1(8643):902\u20133.","journal-title":"Lancet"},{"issue":"5","key":"967_CR72","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI114881","volume":"86","author":"A Rotig","year":"1990","unstructured":"Rotig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, et al. Pearson\u2019s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest. 1990;86(5):1601\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"967_CR73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s13023-022-02538-9","volume":"17","author":"A Yoshimi","year":"2022","unstructured":"Yoshimi A, Ishikawa K, Niemeyer C, Grunert SC. Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure. Orphanet J Rare Dis. 2022;17(1):379.","journal-title":"Orphanet J Rare Dis"},{"issue":"20","key":"967_CR74","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM198905183202001","volume":"320","author":"CT Moraes","year":"1989","unstructured":"Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. New Engl J Med. 1989;320(20):1293\u20139.","journal-title":"New Engl J Med"},{"issue":"7","key":"967_CR75","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/stem.1354","volume":"31","author":"AB Cherry","year":"2013","unstructured":"Cherry AB, Gagne KE, McLoughlin EM, Baccei A, Gorman B, Hartung O, et al. Induced pluripotent stem cells with a mitochondrial DNA deletion. Stem Cells. 2013;31(7):1287\u201397.","journal-title":"Stem Cells"},{"issue":"3","key":"967_CR76","doi-asserted-by":"crossref","first-page":"dmm049083","DOI":"10.1242\/dmm.049083","volume":"15","author":"C Hern\u00e1ndez-Ainsa","year":"2022","unstructured":"Hern\u00e1ndez-Ainsa C, L\u00f3pez-Gallardo E, Garc\u00eda-Jim\u00e9nez MC, Climent-Alcal\u00e1 FJ, Rodr\u00edguez-Vigil C, Garc\u00eda Fern\u00e1ndez de Villalta M, et al. Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome. Dis Model Mech. 2022;15(3):dmm049083.","journal-title":"Dis Model Mech"},{"issue":"3","key":"967_CR77","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/cells10030568","volume":"10","author":"G Lester Sequiera","year":"2021","unstructured":"Lester Sequiera G, Srivastava A, Alagarsamy KN, Rockman-Greenberg C, Dhingra S. Generation and evaluation of isogenic iPSC as a source of cell replacement therapies in patients with Kearns Sayre Syndrome. Cells. 2021;10(3):568.","journal-title":"Cells"},{"key":"967_CR78","volume":"53","author":"A Srivastava","year":"2021","unstructured":"Srivastava A, Lester Sequiera G, Narayan Alagarsamy K, Rockman-Greenberg C, Dhingra S. Generation of human induced pluripotent stem cell (hiPSC) line UOMi005-A from PBMCs of a patient with Kearns-Sayre syndrome. Stem Cell Res. 2021;53: 102283.","journal-title":"Stem Cell Res"},{"issue":"38","key":"967_CR79","doi-asserted-by":"crossref","first-page":"E3622","DOI":"10.1073\/pnas.1311660110","volume":"110","author":"RH Hamalainen","year":"2013","unstructured":"Hamalainen RH, Manninen T, Koivumaki H, Kislin M, Otonkoski T, Suomalainen A. Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model. Proc Natl Acad Sci USA. 2013;110(38):E3622-30.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"967_CR80","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/stem.1389","volume":"31","author":"CD Folmes","year":"2013","unstructured":"Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, et al. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells. 2013;31(7):1298\u2013308.","journal-title":"Stem Cells"},{"issue":"3","key":"967_CR81","doi-asserted-by":"crossref","first-page":"107538","DOI":"10.1016\/j.celrep.2020.107538","volume":"31","author":"TM Klein Gunnewiek","year":"2020","unstructured":"Klein Gunnewiek TM, Van Hugte EJH, Frega M, Guardia GS, Foreman K, Panneman D, et al. m.3243A>G-induced mitochondrial dysfunction impairs human neuronal development and reduces neuronal network activity and synchronicity. Cell Rep. 2020;31(3):107538.","journal-title":"Cell Rep"},{"issue":"7564","key":"967_CR82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature14546","volume":"524","author":"H Ma","year":"2015","unstructured":"Ma H, Folmes CD, Wu J, Morey R, Mora-Castilla S, Ocampo A, et al. Metabolic rescue in pluripotent cells from patients with mtDNA disease. Nature. 2015;524(7564):234\u20138.","journal-title":"Nature"},{"key":"967_CR83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-015-0227-x","volume":"3","author":"H Hatakeyama","year":"2015","unstructured":"Hatakeyama H, Katayama A, Komaki H, Nishino I, Goto Y. Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNATrp. Acta Neuropathol Commun. 2015;3:52.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"967_CR84","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1038\/s41598-017-12396-2","volume":"7","author":"V Chichagova","year":"2017","unstructured":"Chichagova V, Hallam D, Collin J, Buskin A, Saretzki G, Armstrong L, et al. Human iPSC disease modelling reveals functional and structural defects in retinal pigment epithelial cells harbouring the m.3243A>G mitochondrial DNA mutation. Sci Rep. 2017;7(1):12320.","journal-title":"Sci Rep"},{"issue":"1","key":"967_CR85","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13287-022-02937-6","volume":"13","author":"S Bhattacharya","year":"2022","unstructured":"Bhattacharya S, Yin J, Huo W, Chaum E. Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells. Stem Cell Res Ther. 2022;13(1):260.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"967_CR86","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-019-2036-9","volume":"10","author":"NMQ Pek","year":"2019","unstructured":"Pek NMQ, Phua QH, Ho BX, Pang JKS, Hor JH, An O, et al. Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells. Cell Death Dis. 2019;10(11):802.","journal-title":"Cell Death Dis"},{"issue":"16","key":"967_CR87","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3390\/cells11162593","volume":"11","author":"S Ryytty","year":"2022","unstructured":"Ryytty S, Modi SR, Naumenko N, Shakirzyanova A, Rahman MO, Vaara M, et al. Varied responses to a high m.3243A>G mutation load and respiratory chain dysfunction in patient-derived cardiomyocytes. Cells. 2022;11(16):2593.","journal-title":"Cells"},{"issue":"1","key":"967_CR88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/cells8010065","volume":"8","author":"DS Lin","year":"2019","unstructured":"Lin DS, Huang YW, Ho CS, Hung PL, Hsu MH, Wang TJ, et al. Oxidative insults and mitochondrial DNA mutation promote enhanced autophagy and mitophagy compromising cell viability in pluripotent cell model of mitochondrial disease. Cells. 2019;8(1):65.","journal-title":"Cells"},{"issue":"1","key":"967_CR89","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.484","volume":"8","author":"M Yokota","year":"2017","unstructured":"Yokota M, Hatakeyama H, Ono Y, Kanazawa M, Goto YI. Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs. Cell Death Dis. 2017;8(1): e2551.","journal-title":"Cell Death Dis"},{"issue":"3","key":"967_CR90","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41419-020-2383-6","volume":"11","author":"N Winanto","year":"2020","unstructured":"Winanto N, Khong ZJ, Soh BS, Fan Y, Ng SY. Organoid cultures of MELAS neural cells reveal hyperactive Notch signaling that impacts neurodevelopment. Cell Death Dis. 2020;11(3):182.","journal-title":"Cell Death Dis"},{"issue":"3","key":"967_CR91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13238-017-0499-y","volume":"9","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wu H, Kang X, Liang Y, Lan T, Li T, et al. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs. Protein Cell. 2018;9(3):283\u201397.","journal-title":"Protein Cell"},{"issue":"1","key":"967_CR92","doi-asserted-by":"crossref","first-page":"15557","DOI":"10.1038\/s41598-017-15871-y","volume":"7","author":"N Yahata","year":"2017","unstructured":"Yahata N, Matsumoto Y, Omi M, Yamamoto N, Hata R. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation. Sci Rep. 2017;7(1):15557.","journal-title":"Sci Rep"},{"issue":"3","key":"967_CR93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41589-020-00676-4","volume":"17","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi H, Hatakeyama H, Nishimura H, Yokota M, Suzuki S, Tomabechi Y, et al. Chemical reversal of abnormalities in cells carrying mitochondrial DNA mutations. Nat Chem Biol. 2021;17(3):335\u201343.","journal-title":"Nat Chem Biol"},{"issue":"Database issue","key":"967_CR94","doi-asserted-by":"crossref","first-page":"D823","DOI":"10.1093\/nar\/gkl927","volume":"35","author":"E Ruiz-Pesini","year":"2007","unstructured":"Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res. 2007;35(Database issue):D823-8.","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"967_CR95","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116(1\u20132):4\u201312.","journal-title":"Mol Genet Metab"},{"issue":"23","key":"967_CR96","doi-asserted-by":"crossref","first-page":"11164","DOI":"10.1073\/pnas.89.23.11164","volume":"89","author":"M Yoneda","year":"1992","unstructured":"Yoneda M, Chomyn A, Martinuzzi A, Hurko O, Attardi G. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci USA. 1992;89(23):11164\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"967_CR97","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/MCB.01614-09","volume":"30","author":"R Li","year":"2010","unstructured":"Li R, Guan MX. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes. Mol Cell Biol. 2010;30(9):2147\u201354.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"967_CR98","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.celrep.2016.06.067","volume":"16","author":"GC Tan","year":"2016","unstructured":"Tan GC, Mazzoni EO, Wichterle H. Iterative role of Notch signaling in spinal motor neuron diversification. Cell Rep. 2016;16(4):907\u201316.","journal-title":"Cell Rep"},{"issue":"2","key":"967_CR99","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4522(99)00157-8","volume":"93","author":"O Berezovska","year":"1999","unstructured":"Berezovska O, McLean P, Knowles R, Frosh M, Lu FM, Lux SE, et al. Notch1 inhibits neurite outgrowth in postmitotic primary neurons. Neuroscience. 1999;93(2):433\u20139.","journal-title":"Neuroscience"},{"key":"967_CR100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.seizure.2017.06.010","volume":"50","author":"J Finsterer","year":"2017","unstructured":"Finsterer J, Zarrouk-Mahjoub S. Management of epilepsy in MERRF syndrome. Seizure. 2017;50:166\u201370.","journal-title":"Seizure"},{"key":"967_CR101","doi-asserted-by":"crossref","first-page":"23661","DOI":"10.1038\/srep23661","volume":"6","author":"SJ Chou","year":"2016","unstructured":"Chou SJ, Tseng WL, Chen CT, Lai YF, Chien CS, Chang YL, et al. Impaired ROS scavenging system in human induced pluripotent stem cells generated from patients with MERRF syndrome. Sci Rep. 2016;6:23661.","journal-title":"Sci Rep"},{"issue":"4","key":"967_CR102","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41419-018-0488-y","volume":"9","author":"YC Chen","year":"2018","unstructured":"Chen YC, Tsai CL, Wei YH, Wu YT, Hsu WT, Lin HC, et al. ATOH1\/RFX1\/RFX3 transcription factors facilitate the differentiation and characterisation of inner ear hair cell-like cells from patient-specific induced pluripotent stem cells harbouring A8344G mutation of mitochondrial DNA. Cell Death Dis. 2018;9(4):437.","journal-title":"Cell Death Dis"},{"issue":"5","key":"967_CR103","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbamcr.2019.02.010","volume":"1866","author":"M Villanueva-Paz","year":"2019","unstructured":"Villanueva-Paz M, Povea-Cabello S, Villalon-Garcia I, Suarez-Rivero JM, Alvarez-Cordoba M, de la Mata M, et al. Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming. Biochim Biophys Acta Mol Cell Res. 2019;1866(5):861\u201381.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"967_CR104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-821751-1.00015-4","volume":"194","author":"S Rahman","year":"2023","unstructured":"Rahman S. Leigh syndrome. Handbook Clin Neurol. 2023;194:43\u201363.","journal-title":"Handbook Clin Neurol"},{"issue":"2","key":"967_CR105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","volume":"79","author":"NJ Lake","year":"2016","unstructured":"Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79(2):190\u2013203.","journal-title":"Ann Neurol"},{"issue":"4","key":"967_CR106","first-page":"852","volume":"50","author":"Y Tatuch","year":"1992","unstructured":"Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JTR, Wherret J, Smith C, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 1992;50(4):852\u20138.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"967_CR107","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2016.12.013","volume":"20","author":"C Lorenz","year":"2017","unstructured":"Lorenz C, Lesimple P, Bukowiecki R, Zink A, Inak G, Mlody B, et al. Human iPSC-derived neural progenitors are an effective drugdiscovery model for neurological mtDNA disorders. Cell Stem Cell. 2017;20(5):659-74.e9.","journal-title":"Cell Stem Cell"},{"key":"967_CR108","doi-asserted-by":"crossref","first-page":"e13378","DOI":"10.7554\/eLife.13378","volume":"5","author":"X Zheng","year":"2016","unstructured":"Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, et al. Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife. 2016;5:e13378.","journal-title":"Elife"},{"key":"967_CR109","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102572","volume":"57","author":"F Meshrkey","year":"2021","unstructured":"Meshrkey F, Cabrera Ayuso A, Rao RR, Iyer S. Quantitative analysis of mitochondrial morphologies in human induced pluripotent stem cells for Leigh syndrome. Stem Cell Res. 2021;57: 102572.","journal-title":"Stem Cell Res"},{"issue":"9","key":"967_CR110","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.3390\/ijms21093191","volume":"21","author":"T Galera-Monge","year":"2020","unstructured":"Galera-Monge T, Zurita-Diaz F, Canals I, Hansen MG, Rufian-Vazquez L, Ehinger JK, et al. Mitochondrial dysfunction and calcium dysregulation in Leigh syndrome induced pluripotent stem cell derived neurons. Int J Mol Sci. 2020;21(9):3191.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"967_CR111","doi-asserted-by":"crossref","first-page":"dev199914","DOI":"10.1242\/dev.199914","volume":"149","author":"AI Romero-Morales","year":"2022","unstructured":"Romero-Morales AI, Robertson GL, Rastogi A, Rasmussen ML, Temuri H, McElroy GS, et al. Human iPSC-derived cerebral organoids model features of Leigh syndrome and reveal abnormal corticogenesis. Development. 2022;149(20):dev199914.","journal-title":"Development"},{"issue":"6","key":"967_CR112","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/hmg\/ddab299","volume":"31","author":"S Kenvin","year":"2022","unstructured":"Kenvin S, Torregrosa-Munumer R, Reidelbach M, Pennonen J, Turkia JJ, Rannila E, et al. Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism. Hum Mol Genet. 2022;31(6):958\u201374.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"967_CR113","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.18632\/aging.101231","volume":"9","author":"RCB Wong","year":"2017","unstructured":"Wong RCB, Lim SY, Hung SSC, Jackson S, Khan S, Van Bergen NJ, et al. Mitochondrial replacement in an iPSC model of Leber\u2019s hereditary optic neuropathy. Aging. 2017;9(4):1341\u201350.","journal-title":"Aging"},{"issue":"2","key":"967_CR114","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.yexcr.2018.01.020","volume":"363","author":"YR Wu","year":"2018","unstructured":"Wu YR, Wang AG, Chen YT, Yarmishyn AA, Buddhakosai W, Yang TC, et al. Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber\u2019s hereditary optic neuropathy. Exp Cell Res. 2018;363(2):299\u2013309.","journal-title":"Exp Cell Res"},{"issue":"9","key":"967_CR115","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/hmg\/ddaa063","volume":"29","author":"TC Yang","year":"2020","unstructured":"Yang TC, Yarmishyn AA, Yang YP, Lu PC, Chou SJ, Wang ML, et al. Mitochondrial transport mediates survival of retinal ganglion cells in affected LHON patients. Hum Mol Genet. 2020;29(9):1454\u201364.","journal-title":"Hum Mol Genet"},{"key":"967_CR116","doi-asserted-by":"crossref","first-page":"101939","DOI":"10.1016\/j.scr.2020.101939","volume":"48","author":"C Peron","year":"2020","unstructured":"Peron C, Mauceri R, Cabassi T, Segnali A, Maresca A, Iannielli A, et al. Generation of a human iPSC line, FINCBi001-A, carrying a homoplasmic m.G3460A mutation in MT-ND1 associated with Leber\u2019s Hereditary optic Neuropathy (LHON). Stem Cell Res. 2020;48:101939.","journal-title":"Stem Cell Res"},{"issue":"3","key":"967_CR117","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111124","volume":"40","author":"A Danese","year":"2022","unstructured":"Danese A, Patergnani S, Maresca A, Peron C, Raimondi A, Caporali L, et al. Pathological mitophagy disrupts mitochondrial homeostasis in Leber\u2019s hereditary optic neuropathy. Cell Rep. 2022;40(3): 111124.","journal-title":"Cell Rep"},{"key":"967_CR118","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/164_2017_2","volume":"240","author":"DC Wallace","year":"2017","unstructured":"Wallace DC, Lott MT. Leber hereditary optic neuropathy: exemplar of an mtDNA disease. Handb Exp Pharmacol. 2017;240:339\u201376.","journal-title":"Handb Exp Pharmacol"},{"key":"967_CR119","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-821751-1.00010-5","volume":"194","author":"V Carelli","year":"2023","unstructured":"Carelli V, La Morgia C, Yu-Wai-Man P. Mitochondrial optic neuropathies. Handb Clin Neurol. 2023;194:23\u201342.","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"967_CR120","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1167\/iovs.14-16158","volume":"56","author":"P Jiang","year":"2015","unstructured":"Jiang P, Liang M, Zhang J, Gao Y, He Z, Yu H, et al. Prevalence of mitochondrial ND4 mutations in 1281 Han Chinese subjects with Leber\u2019s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2015;56(8):4778\u201388.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"967_CR121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1167\/iovs.62.9.38","volume":"62","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ji Y, Chen J, Xu M, Wang G, Ci X, et al. Assocation Between Leber\u2019s hereditary optic neuropathy and MT-ND1 3460G>A mutation-induced alterations in mitochondrial function, apoptosis, and mitophagy. Invest Ophthalmol Vis Sci. 2021;62(9):38.","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"19","key":"967_CR122","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/hmg\/ddac109","volume":"31","author":"M Liang","year":"2022","unstructured":"Liang M, Ji Y, Zhang L, Wang X, Hu C, Zhang J, et al. Leber\u2019s hereditary optic neuropathy-associated ND6 14484T > C mutation caused pleiotropic effects on the complex I, RNA homeostasis, apoptosis and mitophagy. Hum Mol Genet. 2022;31(19):3299\u2013312.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"967_CR123","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.preteyeres.2006.05.002","volume":"25","author":"MY Yen","year":"2006","unstructured":"Yen MY, Wang AG, Wei YH. Leber\u2019s hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res. 2006;25(4):381\u201396.","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"967_CR124","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s13238-015-0175-z","volume":"6","author":"C Chen","year":"2015","unstructured":"Chen C, Chen Y, Guan MX. A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation. Protein Cell. 2015;6(12):862\u201370.","journal-title":"Protein Cell"},{"issue":"2","key":"967_CR125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/hmg\/ddac190","volume":"32","author":"Z Nie","year":"2023","unstructured":"Nie Z, Wang C, Chen J, Ji Y, Zhang H, Zhao F, et al. Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber\u2019s hereditary optic neuropathy. Hum Mol Genet. 2023;32(2):231\u201343.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"967_CR126","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/hmg\/ddad001","volume":"32","author":"JR Chen","year":"2023","unstructured":"Chen JR, Chen C, Chen J, Ji Y, Lian Y, Zhang J, et al. Nuclear modifier YARS2 allele correction restored retinal ganglion cells-specific deficiencies in Leber\u2019s hereditary optic neuropathy. Hum Mol Genet. 2023;32(9):1539\u201351.","journal-title":"Hum Mol Genet"},{"issue":"40","key":"967_CR127","doi-asserted-by":"crossref","first-page":"21029","DOI":"10.1074\/jbc.M116.739482","volume":"291","author":"M Wang","year":"2016","unstructured":"Wang M, Liu H, Zheng J, Chen B, Zhou M, Fan W, et al. A deafness- and diabetes-associated tRNA mutation causes deficient pseudouridinylation at position 55 in tRNAGlu and mitochondrial dysfunction. J Biol Chem. 2016;291(40):21029\u201341.","journal-title":"J Biol Chem"},{"issue":"3","key":"967_CR128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/nar\/gkh226","volume":"32","author":"X Li","year":"2004","unstructured":"Li X, Fischel-Ghodsian N, Schwartz F, Yan Q, Friedman RA, Guan MX. Biochemical characterization of the mitochondrial tRNASer(UCN) T7511C mutation associated with nonsyndromic deafness. Nucleic Acids Res. 2004;32(3):867\u201377.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"967_CR129","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1093\/nar\/gku466","volume":"42","author":"S Gong","year":"2014","unstructured":"Gong S, Peng Y, Jiang P, Wang M, Fan M, Wang X, et al. A deafness-associated tRNAHis mutation alters the mitochondrial function, ROS production and membrane potential. Nucleic Acids Res. 2014;42(12):8039\u201348.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"967_CR130","doi-asserted-by":"crossref","first-page":"10974","DOI":"10.1093\/nar\/gkw726","volume":"44","author":"M Wang","year":"2016","unstructured":"Wang M, Peng Y, Zheng J, Zheng B, Jin X, Liu H, et al. A deafness-associated tRNAAsp mutation alters the m1G37 modification, aminoacylation and stability of tRNAAsp and mitochondrial function. Nucleic Acids Res. 2016;44(22):10974\u201385.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"967_CR131","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/nar\/gkaa1225","volume":"49","author":"F Meng","year":"2021","unstructured":"Meng F, Zhou M, Xiao Y, Mao X, Zheng J, Lin J, et al. A deafness-associated tRNA mutation caused pleiotropic effects on the m1G37 modification, processing, stability and aminoacylation of tRNAIle and mitochondrial translation. Nucleic Acids Res. 2021;49(2):1075\u201393.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"967_CR132","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1093\/nar\/gkac720","volume":"50","author":"F Meng","year":"2022","unstructured":"Meng F, Jia Z, Zheng J, Ji Y, Wang J, Xiao Y, et al. A deafness-associated mitochondrial DNA mutation caused pleiotropic effects on DNA replication and tRNA metabolism. Nucleic Acids Res. 2022;50(16):9453\u201369.","journal-title":"Nucleic Acids Res"},{"key":"967_CR133","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.scr.2017.10.024","volume":"25","author":"YH Hsu","year":"2017","unstructured":"Hsu YH, Wu YT, Huang CY, Ho MC, Cheng YC, et al. Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene. Stem Cell Res. 2017;25:245\u20139.","journal-title":"Stem Cell Res"},{"issue":"18","key":"967_CR134","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1093\/hmg\/ddac096","volume":"31","author":"C Chen","year":"2022","unstructured":"Chen C, Guan MX. Genetic correction of TRMU allele restored the mitochondrial dysfunction-induced deficiencies in iPSCs-derived hair cells of hearing-impaired patients. Hum Mol Genet. 2022;31(18):3068\u201382.","journal-title":"Hum Mol Genet"},{"issue":"18","key":"967_CR135","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.15252\/embj.201694892","volume":"35","author":"E Perales-Clemente","year":"2016","unstructured":"Perales-Clemente E, Cook AN, Evans JM, Roellinger S, Secreto F, Emmanuele V, et al. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability. EMBO J. 2016;35(18):1979\u201390.","journal-title":"EMBO J"},{"issue":"5","key":"967_CR136","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.stem.2016.02.005","volume":"18","author":"E Kang","year":"2016","unstructured":"Kang E, Wang X, Tippner-Hedges R, Ma H, Folmes CD, Gutierrez NM, et al. Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs. Cell Stem Cell. 2016;18(5):625\u201336.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"967_CR137","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.stemcr.2018.05.007","volume":"11","author":"F Zambelli","year":"2018","unstructured":"Zambelli F, Mertens J, Dziedzicka D, Sterckx J, Markouli C, Keller A, et al. Random mutagenesis, clonal events, and embryonic or somatic origin determine the mtDNA variant type and load in human pluripotent stem cells. Stem Cell Reports. 2018;11(1):102\u201314.","journal-title":"Stem Cell Reports"},{"issue":"10","key":"967_CR138","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41587-019-0227-7","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse T, Hu X, Agbor-Enoh S, Koch M, Spitzer MH, Gravina A, et al. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans. Nat Biotechnol. 2019;37(10):1137\u201344.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"967_CR139","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, Thayer WO, et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol. 2019;37(3):252\u20138.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"967_CR140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-022-00715-9","volume":"18","author":"M Falabella","year":"2022","unstructured":"Falabella M, Minczuk M, Hanna MG, Viscomi C, Pitceathly RDS. Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges. Nat Rev Neurol. 2022;18(11):689\u201398.","journal-title":"Nat Rev Neurol"},{"issue":"7817","key":"967_CR141","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","volume":"583","author":"BY Mok","year":"2020","unstructured":"Mok BY, de Moraes MH, Zeng J, Bosch DE, Kotrys AV, Raguram A, et al. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature. 2020;583(7817):631\u20137.","journal-title":"Nature"},{"issue":"10","key":"967_CR142","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.cell.2022.03.039","volume":"185","author":"SI Cho","year":"2022","unstructured":"Cho SI, Lee S, Mok YG, Lim K, Lee J, Lee JM, et al. Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases. Cell. 2022;185(10):1764-76.e12.","journal-title":"Cell"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-023-00967-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:59:50Z","timestamp":1700240390000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-023-00967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/s12929-023-00967-7","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no proprietary or commercial interest in any of materials discussed in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}